Literature DB >> 15760086

Crystal structure determination of thymoquinone by high-resolution X-ray powder diffraction.

S Pagola1, A Benavente, A Raschi, E Romano, M A A Molina, P W Stephens.   

Abstract

The crystal structure of 2-isopropyl-5-methyl-1,4-benzoquinone (thymoquinone) and its thermal behavior--as necessary physical and chemical properties--were determined in order to enhance the current understanding of thymoquinone chemical action by using high resolution x-ray powder diffraction, Fourier transform infrared spectroscopy (FTIR), and 3 thermo-analytical techniques thermogravimetric analysis (TGA), differential thermal analysis (DTA), and differential scanning calorimetry (DSC). The findings obtained with high-resolution x-ray powder diffraction and molecular location methods based on a simulated annealing algorithm after Rietveld refinement showed that the triclinic unit cell was a = 6.73728(8) A, b = 6.91560(8) A, c = 10.4988(2) A, alpha = 88.864(2) degrees, beta = 82.449(1) degrees, gamma = 77.0299(9) degrees; cell volume = 472.52(1) A3, Z = 2, and space group P1. In addition, FTIR spectrum revealed absorption bands corresponding to the carbonyl and C-H stretching of aliphatic and vinylic groups characteristically observed in such p-benzoquinones. Also, a chemical decomposition process starting at 65 degrees C and ending at 213 degrees C was noted when TGA was used. DSC allowed for the determination of onset at 43.55 degrees C and a melting enthalpy value of DeltaH(m) = 110.6 J/g. The low value obtained for the fusion point displayed a van der Waals pattern for molecular binding, and the thermograms performed evidence that thymoquinone can only be found in crystalline triclinic form, as determined by DRX methods.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15760086      PMCID: PMC2750463          DOI: 10.1208/pt050228

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  12 in total

1.  The structure of malaria pigment beta-haematin.

Authors:  S Pagola; P W Stephens; D S Bohle; A D Kosar; S K Madsen
Journal:  Nature       Date:  2000-03-16       Impact factor: 49.962

2.  Thymoquinone attenuates ifosfamide-induced Fanconi syndrome in rats and enhances its antitumor activity in mice.

Authors:  O A Badary
Journal:  J Ethnopharmacol       Date:  1999-11-01       Impact factor: 4.360

3.  Order-disorder phenomena determined by high-resolution powder diffraction: the structures of tetrakis(trimethylsilyl)methane C

Authors: 
Journal:  Acta Crystallogr B       Date:  1999-12-01

4.  Bronchodilator, spasmolytic and calcium antagonist activities of Nigella sativa seeds (Kalonji): a traditional herbal product with multiple medicinal uses.

Authors:  A H Gilani; N Aziz; I M Khurram; K S Chaudhary; A Iqbal
Journal:  J Pak Med Assoc       Date:  2001-03       Impact factor: 0.781

5.  The influence of thymoquinone on doxorubicin-induced hyperlipidemic nephropathy in rats.

Authors:  O A Badary; A B Abdel-Naim; M H Abdel-Wahab; F M Hamada
Journal:  Toxicology       Date:  2000-03-07       Impact factor: 4.221

6.  High performance liquid chromatographic analysis of the pharmacologically active quinones and related compounds in the oil of the black seed (Nigella sativa L.).

Authors:  O A Ghosheh; A A Houdi; P A Crooks
Journal:  J Pharm Biomed Anal       Date:  1999-04       Impact factor: 3.935

7.  Thymoquinone ameliorates the nephrotoxicity induced by cisplatin in rodents and potentiates its antitumor activity.

Authors:  O A Badary; M N Nagi; O A al-Shabanah; H A al-Sawaf; M O al-Sohaibani; A M al-Bekairi
Journal:  Can J Physiol Pharmacol       Date:  1997-12       Impact factor: 2.273

8.  Inhibition of histamine release from mast cells by nigellone.

Authors:  N Chakravarty
Journal:  Ann Allergy       Date:  1993-03

9.  Thymoquinone protects against doxorubicin-induced cardiotoxicity without compromising its antitumor activity.

Authors:  O A al-Shabanah; O A Badary; M N Nagi; N M al-Gharably; A C al-Rikabi; A M al-Bekairi
Journal:  J Exp Clin Cancer Res       Date:  1998-06

10.  The in vitro anti-tumor activity of some crude and purified components of blackseed, Nigella sativa L.

Authors:  D R Worthen; O A Ghosheh; P A Crooks
Journal:  Anticancer Res       Date:  1998 May-Jun       Impact factor: 2.480

View more
  6 in total

1.  Solvent based optimization for extraction and stability of thymoquinone from Nigella sativa Linn. and its quantification using RP-HPLC.

Authors:  Mohammed Shariq Iqbal; Ausaf Ahmad; Brijesh Pandey
Journal:  Physiol Mol Biol Plants       Date:  2018-08-29

2.  From here to eternity - the secret of Pharaohs: Therapeutic potential of black cumin seeds and beyond.

Authors:  Subhash Padhye; Sanjeev Banerjee; Aamir Ahmad; Ramzi Mohammad; Fazlul H Sarkar
Journal:  Cancer Ther       Date:  2008

3.  A Practical Synthesis and X-ray Crystallographic Analysis of Dithymoquinone, a Photodimer of Thymoquinone.

Authors:  Alan L Myers; Yan-Ping Zhang; Mark A Kramer; William G Bornmann; Ahmed Kaseb; Peiying Yang; Hai T Tran
Journal:  Lett Org Chem       Date:  2012-12-01       Impact factor: 0.867

4.  The Mould War: Developing an Armamentarium against Fungal Pathogens Utilising Thymoquinone, Ocimene, and Miramistin within Bacterial Cellulose Matrices.

Authors:  Sam Swingler; Abhishek Gupta; Hazel Gibson; Wayne Heaselgrave; Marek Kowalczuk; Grazyna Adamus; Iza Radecka
Journal:  Materials (Basel)       Date:  2021-05-18       Impact factor: 3.623

5.  Solubility Determination, Hansen Solubility Parameters and Thermodynamic Evaluation of Thymoquinone in (Isopropanol + Water) Compositions.

Authors:  Mohammed Ghazwani; M Yasmin Begum; Prawez Alam; Mohammed H Alqarni; Hasan S Yusufoglu; Faiyaz Shakeel
Journal:  Molecules       Date:  2021-05-26       Impact factor: 4.411

6.  Development and evaluation of thymoquinone-encapsulated chitosan nanoparticles for nose-to-brain targeting: a pharmacoscintigraphic study.

Authors:  Sanjar Alam; Zeenat I Khan; Gulam Mustafa; Manish Kumar; Fakhrul Islam; Aseem Bhatnagar; Farhan J Ahmad
Journal:  Int J Nanomedicine       Date:  2012-11-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.